Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, K. B. Nolop, Prabha N. Ibrahim et al.|Nature|2010Cited by 1.8k
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective mannerEric W. Joseph, Neal Rosen, Christine A. Pratilas et al.|Proceedings of the National Academy of Sciences|2010Cited by 447